A stark new report sends shockwaves through the tech sector, warning that the multi-billion pound AI investment boom could be a bubble destined to burst, resulting in catastrophic losses for investors as major stocks tumble.
Nvidia has dethroned Microsoft to become the world's most valuable public company, its staggering market surge fuelled by the artificial intelligence boom. The seismic shift caps a remarkable period for the chipmaker, whose technology powers the AI revolu
Nvidia's historic $500 billion market crash triggers global stock sell-off as Asian markets tumble and Wall Street braces for impact. Powell's testimony and geopolitical tensions add to the turmoil.
Stock markets surge, oil prices rise, and Ukrainian President Zelenskyy holds talks with Donald Trump amid Jackson Hole summit anticipation. UK house prices dip in August.
Fresh US tariffs on Chinese goods trigger market volatility as China's economy shows signs of weakening. How UK stocks are responding.
Legendary investor Warren Buffett has acquired a significant stake in UnitedHealth Group, signalling confidence in the healthcare giant. Here’s why this move matters.
The US Food and Drug Administration (FDA) has approved a new Alzheimer's treatment, sparking debate over its efficacy and high cost while offering hope to millions.
Shares in major European pharmaceutical firms plummet as investors react to potential US tariffs, sparking market volatility and sector-wide uncertainty.
Sales of Novo Nordisk's blockbuster diabetes medications, including Ozempic, have dropped unexpectedly. Experts weigh in on the causes and future implications.
Former US President Donald Trump has floated the idea of imposing tariffs on imported pharmaceuticals, a move that could significantly impact the UK's healthcare sector and drug prices.
Former President Donald Trump’s controversial proposal to slash drug prices has reignited tensions with pharmaceutical giants. Critics warn of risks to innovation, while advocates hail it as a win for patients.
Analysts predict Palantir Technologies could be a top-performing stock by 2025. Discover why this data analytics giant is gaining traction among investors.
Labour leader Keir Starmer vows to confront pharmaceutical giants over soaring drug prices, promising relief for the NHS and patients. Will his strategy work?
Former US President Donald Trump calls on British pharmaceutical companies to reduce drug prices for the NHS, sparking debate on healthcare affordability.
New US tariffs could drastically increase the cost of essential medicines in Australia, putting the Pharmaceutical Benefits Scheme at risk. Experts warn of dire consequences for patients.
Former House Speaker Nancy Pelosi engaged in a heated debate with CNN's Jake Tapper over allegations of insider trading linked to Donald Trump. The fiery exchange has sparked fresh controversy in US politics.
Biotech leader Moderna announces major layoffs, axing 150 jobs as part of a strategic cost-reduction plan. What does this mean for the future of mRNA vaccines?
The FTSE 100 surged as investors welcomed positive economic signals. Discover the latest market movements and key stock performances.
AstraZeneca's CEO highlights the critical role of the US market amid looming Trump tariffs, emphasising the need for stable trade policies to sustain pharmaceutical innovation.
Novo Nordisk's blockbuster weight-loss drug Wegovy drives record sales, boosting shares and intensifying competition with Eli Lilly.
Pharmaceutical giant AstraZeneca faces a sharp decline in share prices following an unfavourable US court ruling, sparking investor concerns.
The meme stock phenomenon is back, with retail investors rallying behind struggling companies and causing massive volatility. Experts warn of risks as history repeats itself.
A US couple has been sentenced after authorities discovered their home packed with illegal erectile dysfunction drugs worth thousands.
Asian stock markets, including Japan and the Philippines, surged as investor confidence grew following positive economic signals. Analysts highlight key factors driving the rally.
As Google prepares to announce its second-quarter earnings, analysts predict strong growth in AI and cloud services. Here’s what to expect from the tech giant’s financial report.
Shares in GameStop and Trump Media plummet as meme stock frenzy fizzles. Analysts warn of volatility amid retail investor pullback and shifting market dynamics.
Pharmaceutical giant AstraZeneca announces a bold $1.5bn US expansion despite looming tariff threats from the Trump administration, signalling confidence in transatlantic trade resilience.
Chancellor Rachel Reeves unveils plans to reform ISAs, encouraging UK investors to shift from cash savings to stocks and shares for better long-term growth.
Wall Street rallies as US inflation data fuels optimism, with the Dow Jones and Nasdaq Composite hitting record highs. How will this impact London and global markets?
European shares, including London's FTSE 100, faced declines amid economic uncertainty and weak corporate earnings. Discover the key factors driving the market downturn.